ArticleMolecular biology reports2026
Oral administration of ultrafine-grained Astragalus membranaceus enhances peripheral immunity in weaned black Xiangdong goats by upregulating the complement regulator C4bp and immunoglobulin responses.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Astragalus membranaceus is a widely used immunomodulatory herb in traditional Chinese medicine; however, the effects of its ultrafine-grained powder (UGAM) on the peripheral immune system of young ruminants remain largely unexplored. Thirty-six weaned black Xiangdong goats (postnatal day 42; 5.34 ± 1.342 kg) were randomly allocated to a control group (n = 16; basal diet only) and a UGAM group (n = 20; control plus 10 g/d UGAM) from postnatal days 43-78, including 8 days adaption period. On postnatal day 78, blood samples were analyzed for complement proteins (C1q, C1r, C1s, C3, C4, C4bp, and Factor H), immunoglobulins (IgA, IgG, and IgM), and inflammatory cytokines (IL-1α, IL-1β, IL-6, IL-10, TNF-α, and IFN-γ), along with peripheral blood cell profiles. Hepatic complement gene expression was measured in a randomly selected subset of animals (Control n = 11; UGAM n = 16) using RT-qPCR. UGAM significantly increased serum C4bp concentrations and serum and hepatic C4bp mRNA expression (p < 0.001) and increased peripheral IgM concentrations (p = 0.032), whereas IgA, IgG, and all measured inflammatory cytokines (IL-1α, IL-1β, IL-6, IL-10, TNF-α, and IFN-γ) remained unchanged (p > 0.05). In the multi-parameter analysis, UGAM treatment was independently and positively associated with C4bp (partial r = 0.74, p < 0.001), and the overall correlation structure of the complement system was positively associated with that of the immunoglobulins (Mantel r = 0.36, p = 0.001). Oral administration of UGAM increased circulating C4bp and IgM and hepatic C4bp in weaned goats, consistent with engagement of homeostatic complement regulatary and possible post-weaning immune support. However, complement activity, plasma-cell responses, signaling, and safety were not measured; mechanisms remain hypothetical and require validation.
Indexed as
Identifiers
42848100What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.